This website provides current and important information on pharmaceutical policy and regulation in the areas of:
- Canadian pharmaceutical regulation in comparison to countries globally,
- the influence of conflicts of interest (COI) (financial and otherwise) on drug promotion, regulation, and clinical trial data reporting,
- industry strategies to promote prescription medications (i.e. data suppression, misrepresentation, falsification),
- Canada and United States pharmaceutical litigation (personal injury as a result of hidden adverse events from prescription medications),
- pharmaceutical manufacturing and product safety,
- clinical trial research and safety,
- Canadian physicians' prescribing choices based on the current medical education environment, which is largely supported by industry, and
- patient safety as a result of these prescribing choices.
Link category: